The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo


First IMI Ebola projects get underway

IMI is launching the first eight projects of its Ebola+ programme, covering vaccine development, manufacture and uptake as well as diagnostics.


  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • Get on-course!

    With over 5 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI's 46 projects have a combined budget of €1.6 billion and are tackling some of the toughest challenges in drug development.

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Schizophrenia breakthrough

    NEWMEDS project research published in Nature reveals that genetic variants linked with schizophrenia have an impact in healthy carriers

    ... more
All projects


IMI 2 - Call 3 is open for submission of proposals

 - remote assessment of disease
 - neuropsychiatry
 - type 2 diabetes
 - vaccine manufacture
 - pertussis vaccination
 - patient focused medicine development


  • 27/02/2015 : The Feb newsletter is online- it's been a busy month for our projects on #autism #schizophrenia #antibiotics & more
  • 27/02/2015 : RT @Open_PHACTS: Presentations and photos from last week's Open PHACTS workshop at @UniversidadeUSC are online! http…
  • 26/02/2015 : RT @PROTECT_BR: The materials presented at the Benefit-Risk Workshop of the PROTECT Symposium at the EMA are now available on

Follow us on Twitter